Sleep health company SleepScore Labs reported on Tuesday the completion of the acquisition of Sleep.ai and its wearable and digital app that detects snoring and bruxism.
Sleep.ai is a digital health company specialised in highly sophisticated analysis during sleep using a mobile device. The apps use special algorithms to filter and detect snoring. It offers a CE-certified app specialised in detecting teeth grinding during sleep. The app gives the option to track progress over time, and if needed, can recommend a local medical professional if the condition is of concern. Sleep.ai reportedly created an app and wearable for detecting if a user is snoring and/or grinding their teeth, known as bruxism and helps dentists monitor patients after they've begun dental treatment for either condition.
Additionally, the Sleep.ai app has been downloaded more than 250,000 times from the App Store and Google Play store and Sleep.ai apps will still be available on its own website as well as SleepScore Labs'.
Following closing, Sleep.ai's founder and CEO Michiel Allessie, a Dutch board-certified sleep dentist, will join the SleepScore Labs team in Carlsbad, Calif., as vice president of Snoring and Bruxism to continue advancing the latest technologies in detecting sleep issues.
The terms of the acquisition were not disclosed by the companies.
Novocure announces presentation of new TTFields research at EANO and ESMO 2025 meetings
OSR Holdings to acquire Korean non-invasive glucose monitor developer Woori IO
Autonomix Medical secures new US patent to expand precision nerve-targeted therapies
MedHub-AI's AutocathFFR receives national reimbursement approval in Japan
Microbot Medical secures first Japanese patent for Liberty robotic system following FDA clearance
Polarean Imaging signs new supply agreementwith UVA Health for clinical Xenon MRI
Femasys partners with Kebomed to expand FemBloc permanent birth control in France and Benelux
Implantica receives positive FDA feedback on final RefluxStop PMA submission
Tempus secures FDA clearance for RNA-based xR IVD diagnostic device
Shoulder Innovations expands I-Series portfolio with launch of InSet 70 Humeral Stem